Daily Chemical News Recommendation ( Sept. 27 2018)

ECHEMI will recommend you several daily chemical news. If you want to know more, please go to our News Section.

 >> Cipla's new triple combination ARV approved in South Africa

The South African Health Products Regulatory Authority (SAHPRA) has approved Cipla’s latest first-line triple-combination antiretroviral (ARV) treatment for HIV. The new combination medicine, commonly referred to as TLD, is a combination of tenofovir (TDF), lamivudine (3TC) and dolutegravir (DTG).

In future, TLD will be manufactured at Cipla’s facilities in Durban and Uganda, reinforcing Cipla’s commitment to produce medicines in Africa for Africa and ensuring more affordable treatment for patients.[More]

>>SABIC and Clariant tighten partnership by combining portfolios in high performan

Switzerland-headquartered speciality chemicals company, Clariant, and Saudi Arabia’s petrochemical giant, SABIC, have tightened their partnership, by agreeing to pool their specialities business into a new Business Area (BA) to be called High Performance Materials (HPM). This will include some parts of SABIC’s advanced engineering plastics, and all of Clariant’s polymer additives and high value masterbatches businesses now part of the BA Plastics and Coatings. At the same time, Clariant has also announced the divestment by 2020 of its remaining Plastics and Coatings business, which includes the pigments, standard masterbatches and medical specialities. The rest of the BAs at Clariant – Care Chemicals, Catalysis and Natural Resources – are to stay unchanged.  [More]